Tagged with BI

Korea Cure Therapeutics is a startup developing gene and cell therapies in Korea. Its founder David Kim explains where his passion for regenerative therapies stems from, breaks down the main hurdles standing in the way of success and describes how his company’s business model focused on flexibility and development speed through…

China Samantha Du, Chairman and CEO of Zai Lab, the flagship China biotech company, shares her inspirational story of being one of the pioneers to forge a path for Chinese biopharma innovation; the recent product launch of Optune® in Hong Kong in December 2018, Zai Lab’s second product on the market;…

Korea After a long career at leading diagnostics companies in research and business development roles, Young Kuk Yun decided to use his accumulated experience to start a venture dedicated to providing access to the technology and know-how required to perform translational biomedical research and develop companion diagnostics tools for biopharmaceutical companies…

Israel Saul Kaye of iCAN and CannaTech outlines a compelling case for Israel to be considered one of the world’s leading hostpots for medical cannabis; drawing on its R&D history, specific population needs, climate, advanced agricultural methods, and the willingness of the Israeli state to embrace what is still an emerging…

Korea Steve Hong, CEO, and Tony Lim, vice president & COO of Lemon Healthcare, lift the lid on the new streamlined hospital data services they are offering, and the benefits to speed and cost effectiveness that they will bring to healthcare providers and patients. Lim also reveals his strategy to expand…

Spain Aurora Berra, general manager of Sobi Spain and Portugal, highlights her key priorities and the opportunities and challenges inherent in the fragmented Spanish healthcare system. Berra gives insight into the need for a bespoke rare disease focus and delivers advice to young women starting their journey in the healthcare industry.…

France Jean-Louis Anspach, general manager of Teva France, elaborates on the affiliate’s transitional restructuring period as they make a turnaround effort in the face of group-wide challenges. Anspach goes on to explain what areas will be driving Teva forward while sharing his views on the French generic and biosimilar environment.  …

Korea James Jungkue Lee, founder and CEO of Bridge Biotherapeutics, explains his strategy for risk mitigation in running a virtual biotech start-up. He also offers his insights into the company’s partnership strategy and shares his opinion on why Korea will become a global leader in biotech.   Biotech is a very…

Egypt Ahmed Mostafa, country manager of Amgen in Egypt and Iran, explains how the affiliate has been growing by providing end-to-end solutions. He also gives his take on the Egyptian government’s prioritization of healthcare and highlights that there are still improvements needed for bringing biosimilars to Egypt.     How would…

Korea Quegen Biotech is a company focusing on manufacturing beta-glucan for use in a range of healthcare products, from hangover cures to oncology treatments. In this interview, Dr Jong Dae Lee explains the benefits of beta glucan, and how he managed to overcome the challenges in its extraction to make it…

China Jay Dong, founding GM (China and APAC) and Global VP of Cell Signaling Technology, shares the company’s success in the past ten years; the economic transformation in China driving the growth of the biotech and pharma industries; the cutting-edge solutions and technologies Cell Signaling Technology is committed to providing to…

Spain Teresa Chavarria Gimenez, director general of planning, research and training at the Ministry of Health of the Community of Madrid, highlights her role and the BioMad initiative as they look to position Madrid on the European and global biotech map.   We want to facilitate the collaboration of the public…